scholarly journals MO19-2 INSIGHT2: Tepotinib + osimertinib in pts with EGFR-mutant NSCLC and acquired resistance to 1L osimertinib due to METamp

2021 ◽  
Vol 32 ◽  
pp. S309
Author(s):  
Masahiro Morise ◽  
Hiroshi Sakai ◽  
Terufumi Kato ◽  
Takaaki Tokito ◽  
Masayuki Takeda ◽  
...  
Keyword(s):  
Acquired Resistance ◽  
Egfr Mutant

scholarly journals 439O Tracking spatiotemporal T790M heterogeneity in patients with EGFR-mutant advanced NSCLC after acquired resistance to EGFR TKIs

2016 ◽  
Vol 27 ◽  
pp. ix140
Author(s):  
Y.-C. Zhang ◽  
C. Pi ◽  
E.-E. Ke ◽  
Z.-H. Chen ◽  
J. Su ◽  
...  
Keyword(s):  
Advanced Nsclc ◽  
Acquired Resistance ◽  
Egfr Mutant ◽  
Egfr Tkis

scholarly journals Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin β3 Signaling in EGFR-Mutant Lung Cancer

2019 ◽  
Vol 18 (12) ◽  
pp. 2357-2367 ◽  
Author(s):  
Caiyun Wang ◽  
Tao Wang ◽  
Dacheng Lv ◽  
Ling Li ◽  
Jinnan Yue ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Acquired Resistance ◽  
Integrin Β3 ◽  
Egfr Mutant ◽  
Egfr Tkis

Abstract 955: Transformation from NSCLC to SCLC in EGFR mutant lung cancers with acquired resistance to EGFR inhibitors

2014 ◽  
Author(s):  
Matthew J. Niederst ◽  
Lecia V. Sequist ◽  
Elizabeth L. Lockerman ◽  
Angel R. Garcia ◽  
Carlotta Costa ◽  
...  
Keyword(s):  
Acquired Resistance ◽  
Egfr Inhibitors ◽  
Lung Cancers ◽  
Egfr Mutant
Sign in / Sign up

Export Citation Format

Share Document